Authors: Schernthaner, GH Spanblochl, E Sperr, WR Sillaber, C Semper, H Jurecka, W Hagen, M Wolff, K Chott, A Lechner, K Valent, P

Citation: Gh. Schernthaner et al., Effects of interferon-alpha 2b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis, ANN HEMATOL, 79(12), 2000, pp. 660-666

Authors: Sillaber, C Gesbert, F Frank, DA Sattler, M Griffin, JD

Citation: C. Sillaber et al., STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells, BLOOD, 95(6), 2000, pp. 2118-2125

Authors: Laffer, S Hogbom, E Adrianson, J Gronlund, H Sillaber, C Valent, P Vangelista, L Kricek, F Kraft, D Valenta, R

Citation: S. Laffer et al., An in vitro model for the allergen-IgE-Fc epsilon RI interaction, INT A AL IM, 118(2-4), 1999, pp. 116-118

Authors: Sillaber, C Walchshofer, S Mosberger, I Gaiger, A Simonitsch, I Chott, A Lechner, K Valent, P

Citation: C. Sillaber et al., Immunophenotypic characterization of human bone marrow endosteal cells, TISSUE ANTI, 53(6), 1999, pp. 559-568

Authors: Sperr, WR Walchshofer, S Horny, HP Fodinger, M Simonitsch, I Fritsche-Polanz, R Schwarzinger, I Tschachler, E Sillaber, C Hagen, W Geissler, K Chott, A Lechner, K Valent, P

Citation: Wr. Sperr et al., Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val, BR J HAEM, 103(3), 1998, pp. 740-749